Cargando...
Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
BACKGROUND: Helicobacter pylori (HP) infection is associated with reduced lung function and systemic inflammation in chronic obstructive pulmonary disease (COPD) patients. Azithromycin (AZ) is active against HP and reduces the risk of COPD exacerbation. We determined whether HP infection status modi...
Gardado en:
| Publicado en: | Respir Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5450077/ https://ncbi.nlm.nih.gov/pubmed/28558695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-017-0594-x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|